University Of Sheffield
University Of Sheffield is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During 26 Weeks of Treatment in Patients with Myotonic Dystrophy Type 1 and Type 2
Sponsor Lupin Atlantis Holdings SA
- Start (EU)
- Latest update
- Estimated end
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR compared to Mexiletine IR in Patients with Non-Dystrophic Myotonias (ACHILLES study)
Sponsor Lupin Atlantis Holdings S.A.
- Start (EU)
- Latest update
- Estimated end
A Phase 2, open-label, multi-centre, multi-national interventional trial to evaluate the efficacy and safety of erdafitinib (ERDA) monotherapy and erdafitinib (ERDA) and cetrelimab (CET) combination as neoadjuvant treatment in cisplatin-ineligible patients with muscle-invasive bladder cancer (MIBC) whose tumours express FGFR gene alterations (SOGUG-NEOWIN)
Sponsor Grupo Espanol De Oncologia Genitourinaria-Socug
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for University Of Sheffield?
The 2026-10-09 snapshot links University Of Sheffield to 3 distinct CTIS trials. Recorded services include • HGRT QMA training • VHOT training • Training on 10mwt and other functional outcome • Chillipharm training, Imaging diagnosis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for University Of Sheffield?
The most frequently recorded therapeutic areas are Genetic and Congenital Disorders, Neurology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to University Of Sheffield conducted?
The linked trials record locations in 6 countries, including Italy, Belgium, Germany, Spain, France. These are trial locations, not confirmed office locations or countries where University Of Sheffield delivered services.
What can this page tell me about University Of Sheffield's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under University Of Sheffield. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- University Of Sheffield